Cassandra L. Hodgkinson
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 22, 2017
Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer.
Journal: Nature medicine
Published: June 08, 2016
Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.
Journal: EMBO molecular medicine
Published: January 14, 2016
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 09, 2015
Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLC.
Journal: Molecular cancer therapeutics
Published: October 30, 2015
Development of a circulating miRNA assay to monitor tumor burden: From mouse to man.
Journal: Molecular oncology
Published: September 10, 2015
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.
Journal: Nature medicine
Published: March 17, 2014
Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 27, 2013
A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers.
Journal: Cell death & disease
Published: May 04, 2013
[18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941.
Journal: Molecular cancer therapeutics
Published: February 22, 2013
Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma.
Journal: Magnetic resonance in medicine
Published: November 27, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026